M

MedPacto Inc
KOSDAQ:235980

Watchlist Manager
MedPacto Inc
KOSDAQ:235980
Watchlist
Price: 6 800 KRW 5.26% Market Closed
Market Cap: 233.1B KRW
No Transactions Found

We don't have any information about MedPacto Inc's insider trading.

Global
Insiders Monitor

MedPacto Inc
Glance View

Market Cap
233.1B KRW
Industry
Biotechnology

MedPacto, Inc. researches and develops anti-cancer drugs. The company is headquartered in Seoul, Seoul. The company went IPO on 2019-12-19. The firm researches and develops anticancer drugs and diagnostic kits including vactosertib, MA-B2 and others. The products are used as the treatment of multiple myeloma, lung cancer, stomach cancer, colon cancer, blood cancer, triple negative breast cancer and pancreatic cancer, among others.

Intrinsic Value
232.42 KRW
Overvaluation 97%
Intrinsic Value
Price
M

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top